103 related articles for article (PubMed ID: 7650670)
1. 4-Aza-3-oxo-5 alpha-androst-1-ene-17 beta-N-aryl-carboxamides as dual inhibitors of human type 1 and type 2 steroid 5 alpha-reductases. Dramatic effect of N-aryl substituents on type 1 and type 2 5 alpha-reductase inhibitory potency.
Bakshi RK; Rasmusson GH; Patel GF; Mosley RT; Chang B; Ellsworth K; Harris GS; Tolman RL
J Med Chem; 1995 Aug; 38(17):3189-92. PubMed ID: 7650670
[No Abstract] [Full Text] [Related]
2. 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro].
Tolman RL; Sahoo SP; Bakshi RK; Gratale D; Patel G; Patel S; Toney J; Chang B; Harris GS
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):303-9. PubMed ID: 9219921
[TBL] [Abstract][Full Text] [Related]
3. Determination of rat 5alpha-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines.
Szécsi M; Ondré D; Tóth I; Magony S; Wölfling J; Schneider G; Julesz J
Acta Biol Hung; 2010 Sep; 61(3):274-81. PubMed ID: 20724274
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor.
Li X; Singh SM; Labrie F
J Med Chem; 1995 Mar; 38(7):1158-73. PubMed ID: 7707319
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a new type of specific competitive inhibitor of testosterone 5 alpha-reductase, in volunteers.
Ohtawa M; Morikawa H; Shimazaki J
Eur J Drug Metab Pharmacokinet; 1991; 16(1):15-21. PubMed ID: 1657611
[TBL] [Abstract][Full Text] [Related]
6. Azasteroids as inhibitors of testosterone 5 alpha-reductase in mammalian skin.
Mellin TN; Busch RD; Rasmusson GH
J Steroid Biochem Mol Biol; 1993 Feb; 44(2):121-31. PubMed ID: 8439517
[TBL] [Abstract][Full Text] [Related]
7. Four-amino acid segment in steroid 5 alpha-reductase 1 confers sensitivity to finasteride, a competitive inhibitor.
Thigpen AE; Russell DW
J Biol Chem; 1992 Apr; 267(12):8577-83. PubMed ID: 1314830
[TBL] [Abstract][Full Text] [Related]
8. Solid phase transition of CS-891 enantiotropes during grinding.
Yada S; Ohya M; Ohuchi Y; Hamaura T; Wakiyama N; Usui F; Kusai A; Yamamoto K
Int J Pharm; 2003 Apr; 255(1-2):69-79. PubMed ID: 12672603
[TBL] [Abstract][Full Text] [Related]
9. Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids.
Thareja S; Rajpoot T; Verma SK
Steroids; 2015 Mar; 95():96-103. PubMed ID: 25582615
[TBL] [Abstract][Full Text] [Related]
10. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
Hirsch KS; Jones CD; Audia JE; Andersson S; McQuaid L; Stamm NB; Neubauer BL; Pennington P; Toomey RE; Russell DW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5277-81. PubMed ID: 8389478
[TBL] [Abstract][Full Text] [Related]
11. Steroidal 5α-Reductase Inhibitors: A Comparative 3D-QSAR Study Review.
Thareja S
Chem Rev; 2015 Apr; 115(8):2883-94. PubMed ID: 25785489
[No Abstract] [Full Text] [Related]
12. Linear relationships between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5alpha-reductase by delta 1-4-azasteroids.
Tian G; Haffner CD
J Biol Chem; 2001 Jun; 276(24):21359-64. PubMed ID: 11279132
[TBL] [Abstract][Full Text] [Related]
13. Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.
Rasmusson GH; Reynolds GF; Steinberg NG; Walton E; Patel GF; Liang T; Cascieri MA; Cheung AH; Brooks JR; Berman C
J Med Chem; 1986 Nov; 29(11):2298-315. PubMed ID: 3783591
[TBL] [Abstract][Full Text] [Related]
14. 19-nor-10-azasteroids: a novel class of inhibitors for human steroid 5alpha-reductases 1 and 2.
Guarna A; Belle C; Machetti F; Occhiato EG; Payne AH; Cassiani C; Comerci A; Danza G; De Bellis A; Dini S; Marrucci A; Serio M
J Med Chem; 1997 Mar; 40(7):1112-29. PubMed ID: 9089333
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic determination of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a 4-azasteroid, in human plasma from a phase I study.
Carlin JR; Christofalo P; Vandenheuvel WJ
J Chromatogr; 1988 May; 427(1):79-91. PubMed ID: 2842353
[TBL] [Abstract][Full Text] [Related]
16. 4,7 beta-Dimethyl-4-azacholestan-3-one (MK-386) and related 4-azasteroids as selective inhibitors of human type 1 5 alpha-reductase.
Bakshi RK; Patel GF; Rasmusson GH; Baginsky WF; Cimis G; Ellsworth K; Chang B; Bull H; Tolman RL; Harris GS
J Med Chem; 1994 Nov; 37(23):3871-4. PubMed ID: 7966146
[No Abstract] [Full Text] [Related]
17. Synthesis and in vitro evaluation of 4-substituted N-(1,1-dimethylethyl)-3-oxo-4-androstene-17 beta-carboxamides as 5 alpha-reductase inhibitors and antiandrogens.
Li X; Singh SM; Côté J; Laplante S; Veilleux R; Labrie F
J Med Chem; 1995 Apr; 38(9):1456-61. PubMed ID: 7739004
[TBL] [Abstract][Full Text] [Related]
18. Azasteroids as inhibitors of rat prostatic 5 alpha-reductase.
Rasmusson GH; Reynolds GF; Utne T; Jobson RB; Primka RL; Berman C; Brooks JR
J Med Chem; 1984 Dec; 27(12):1690-701. PubMed ID: 6502599
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of time-dependent inhibition of 5 alpha-reductases by delta 1-4-azasteroids: toward perfection of rates of time-dependent inhibition by using ligand-binding energies.
Tian G; Mook RA; Moss ML; Frye SV
Biochemistry; 1995 Oct; 34(41):13453-9. PubMed ID: 7577933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
